Roberts Kent Charles II 4
4 · BIOLARGO, INC. · Filed Apr 2, 2020
Insider Transaction Report
Form 4
BIOLARGO, INC.BLGO
Roberts Kent Charles II
Director
Transactions
- Award
Option to Purchase Common Stock
2020-03-31+88,235→ 573,859 totalExercise: $0.17From: 2020-03-31Exp: 2030-03-31→ Common stock (88,235 underlying)
Footnotes (1)
- [F1]This Option was issued to Reporting Person as payment for $15,000 in fees due to Reporting Person by Issuer in exchange for services on its board of directors for the most recently completed quarterly period, pursuant to the Issuer's 2018 Equity Incentive Plan.